Universe Pharmaceuticals (UPC) Receivables (2020 - 2026)
Universe Pharmaceuticals (UPC) posted Receivables of $22.2 million for Q1 2026, up 44.74% sequentially from $15.3 million in Q3 2025.
Universe Pharmaceuticals (UPC) Receivables (2020 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Receivables for 7 years, with the latest figure at $22.2 million in Q1 2026.
- Quarterly Receivables changed N/A year-over-year to $22.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.2 million (changed N/A YoY) and the FY2025 annual result came in at -$3.3 billion, down 117.57% from the prior year.
- Receivables advanced to $22.2 million in Q1 2026 per UPC's latest filing, from $15.3 million in the prior quarter.
- Over five years, Receivables peaked at $18.7 billion in Q3 2024 and troughed at $12.9 million in Q3 2023.
- A 5-year average of $2.4 billion and a median of $17.2 million in 2022 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables jumped 144525.2% in 2024, then plunged 99.92% in 2025.
- Over 5 years, Receivables stood at $16.0 million in 2022, then decreased by 19.03% to $12.9 million in 2023, then surged by 144525.2% to $18.7 billion in 2024, then slumped by 99.92% to $15.3 million in 2025, then soared by 44.74% to $22.2 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $22.2 million, $15.3 million, and $18.7 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Universe Pharmaceuticals | 3.04 Mn | -26.01 Mn | - | 22.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.16 Mn |
| Sep 30, 2025 | 15.31 Mn |
| Sep 30, 2024 | 18.71 Bn |
| Mar 31, 2024 | 14.47 Mn |
| Sep 30, 2023 | 12.94 Mn |
| Mar 31, 2023 | 18.34 Mn |
| Sep 30, 2022 | 15.98 Mn |
| Mar 31, 2022 | 19.73 Mn |
| Sep 30, 2021 | 15.81 Mn |
| Sep 30, 2020 | 11.51 Mn |